Signal active
Investment Firm
Overview
Horizon Discovery Group PLC is a UK life science company that uses gene editing and gene modulation platforms to produce cells, applying them in research and clinical applications that advance human health. The Company’s gene editing and gene modulation platform, are able to alter almost any DNA sequence or RNA transcription, has generated a catalogue of over 1,000,000 cell and reagent products that help researchers recapitulate the genetic and protein anomalies found in diseases like cancer. These models have been adopted by c12, 000 organizations to better understand of the predictors and drivers of disease and drug response, and by Horizon in a range of services offered to customers, as well as in the Company’s own research R&D pipeline.
Highlights
2007
Biotechnology
101-250
1
0
undefined
N/A
N/A
Location
Europe
Contact Information
Social
Profile Resume
Horizon Discovery, established in 2007 and headquartered in Europe., specializes in investments across Biotechnology, Life Science, Pharmaceutical, Education, Universities, Health Care, Chemical, Financial Services, Finance, Government. Their recent investments include Sphere Fluidics, University of Edinburgh, Twist Bioscience, Innovate UK. The highest investment round they participated in was $60.0M. Among their most notable exits are Sphere Fluidics and University of Edinburgh. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
1
0
0
undefined
Investments
1
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Jul 17, 2017 | Sphere Fluidics | Biotechnology | 1.3M |
Exits
0
Funding Timeline
1
15
0
Funding Rounds
1
Horizon Discovery has raised 1 rounds. Their latest funding was raised on Jul 17, 2017 from a Grant - Sphere Fluidics round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Jul 17, 2017 | Grant - Sphere Fluidics | - | 1.3M | - |
Investors
16
Horizon Discovery is funded by 16 investor(s). ValueAct Capital and Future Fifty Kantor are the most recent investors.
Investor Name | Lead Investor | Funding Round | Money Raised |
---|---|---|---|
Roche Venture Fund | No | Venture Round - Horizon Discovery | 10.6M |
Molten Ventures | No | Venture Round - Horizon Discovery | 10.6M |
Future Fifty | Yes | Non Equity Assistance - Horizon Discovery | 0 |
ValueAct Capital | Yes | Post-IPO Equity - Horizon Discovery | 0 |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.